Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Grimmer

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Translational Psychiatry|February 2, 2019
FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutationsJanine Diehl-Schmid, Abigail Licata, Oliver Goldhardt, et al.
Fortschritte Der Neurologie-Psychiatrie|July 20, 2022
[The Cost of Early Diagnosis of Cognitive Decline in German Memory Clinics]Oezguer A Onur, Claus Wolff-Menzler, Christine A F von Arnim, et al.
JAMA Neurology|September 19, 2022
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled TrialsSusanne Ostrowitzki, Tobias Bittner, Kaycee M Sink, et al.
Neurology|September 14, 2018
Serum neurofilament light chain in behavioral variant frontotemporal dementiaPetra Steinacker, Sarah Anderl-Straub, Janine Diehl-Schmid, et al.
Journal of Neuroinflammation|January 23, 2024
Associations between sex, body mass index and the individual microglial response in Alzheimer's diseaseGloria Biechele, Boris-Stephan Rauchmann, Daniel Janowitz, et al.
Annals of Neurology|September 2, 2022
Microglial Activation and Connectivity in Alzheimer Disease and AgingBoris-Stephan Rauchmann, Matthias Brendel, Nicolai Franzmeier, et al.
Plos Medicine|August 21, 2020
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control studyHana Saddiki, Aurore Fayosse, Emmanuel Cognat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersMarco Öchsner, Matthias Brendel, Nicolai Franzmeier, et al.
Acta Neuropathologica|November 24, 2024
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathiesLuna Slemann, Johannes Gnörich, Selina Hummel, et al.
International Journal of Geriatric Psychiatry|September 8, 2020
Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium surveyKristian S Frederiksen, Thomas R Nielsen, Ildebrando Appollonio, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Translational Psychiatry|February 2, 2019
FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutationsJanine Diehl-Schmid, Abigail Licata, Oliver Goldhardt, et al.
Fortschritte Der Neurologie-Psychiatrie|July 20, 2022
[The Cost of Early Diagnosis of Cognitive Decline in German Memory Clinics]Oezguer A Onur, Claus Wolff-Menzler, Christine A F von Arnim, et al.
JAMA Neurology|September 19, 2022
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled TrialsSusanne Ostrowitzki, Tobias Bittner, Kaycee M Sink, et al.
Neurology|September 14, 2018
Serum neurofilament light chain in behavioral variant frontotemporal dementiaPetra Steinacker, Sarah Anderl-Straub, Janine Diehl-Schmid, et al.
Journal of Neuroinflammation|January 23, 2024
Associations between sex, body mass index and the individual microglial response in Alzheimer's diseaseGloria Biechele, Boris-Stephan Rauchmann, Daniel Janowitz, et al.
Annals of Neurology|September 2, 2022
Microglial Activation and Connectivity in Alzheimer Disease and AgingBoris-Stephan Rauchmann, Matthias Brendel, Nicolai Franzmeier, et al.
Plos Medicine|August 21, 2020
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control studyHana Saddiki, Aurore Fayosse, Emmanuel Cognat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersMarco Öchsner, Matthias Brendel, Nicolai Franzmeier, et al.
Acta Neuropathologica|November 24, 2024
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathiesLuna Slemann, Johannes Gnörich, Selina Hummel, et al.
International Journal of Geriatric Psychiatry|September 8, 2020
Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium surveyKristian S Frederiksen, Thomas R Nielsen, Ildebrando Appollonio, et al.
Pageof 19